Literature DB >> 25210300

F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence carcinoma cervix.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Year:  2014        PMID: 25210300      PMCID: PMC4157208          DOI: 10.4103/0972-3919.136609

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


× No keyword cloud information.
Sir, The recent report on F-18 fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET)/computed tomography (CT) in the detection of recurrence carcinoma cervix is very interesting.[1] Bhoil et al. concluded that “PET/CT appears to have an important role in detecting recurrence following primary treatment of cervical cancer.”[1] It is no doubt that the tool can be useful in investigative medicine for searching malignancy. However, there are some concerns on the F-18-FDG PET/CT. Errors can be seen in some cases. The good examples are the errors that can be seen in the case with existed atherosclerotic plaques[2] and lymphadenopathy due to infectious etiologies.[3] To diagnose, the careful interpretation on investigation result accompanied with available history and clinical features of the patients is required.
  3 in total

1.  Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.

Authors:  Heather A Jacene; Vered Stearns; Richard L Wahl
Journal:  Clin Nucl Med       Date:  2006-07       Impact factor: 7.794

2.  F-18 fluorodeoxyglucose uptake in atherosclerotic plaque in the mediastinum mimicking malignancy: another potential for error.

Authors:  Muzammil Z Hanif; Munir Ghesani; Arshad A Shah; Tokuo Kasai
Journal:  Clin Nucl Med       Date:  2004-02       Impact factor: 7.794

3.  Role of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence in patients with cervical cancer.

Authors:  Amit Bhoil; Bhagwant Rai Mittal; Anish Bhattacharya; Sampath Santhosh; Firuza Patel
Journal:  Indian J Nucl Med       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.